631 related articles for article (PubMed ID: 21814197)
1. Chemotherapy-induced peripheral neuropathy: prevention and treatment.
Pachman DR; Barton DL; Watson JC; Loprinzi CL
Clin Pharmacol Ther; 2011 Sep; 90(3):377-87. PubMed ID: 21814197
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
Wolf S; Barton D; Kottschade L; Grothey A; Loprinzi C
Eur J Cancer; 2008 Jul; 44(11):1507-15. PubMed ID: 18571399
[TBL] [Abstract][Full Text] [Related]
3. Serotonin-norepinephrine reuptake inhibitors for the management of chemotherapy-induced peripheral neuropathy.
Aziz MT; Good BL; Lowe DK
Ann Pharmacother; 2014 May; 48(5):626-32. PubMed ID: 24577146
[TBL] [Abstract][Full Text] [Related]
4. Prevention and treatment of chemotherapy-induced peripheral neuropathy.
Piccolo J; Kolesar JM
Am J Health Syst Pharm; 2014 Jan; 71(1):19-25. PubMed ID: 24352178
[TBL] [Abstract][Full Text] [Related]
5. Updating your peripheral neuropathy "know-how".
Marrs J; Newton S
Clin J Oncol Nurs; 2003; 7(3):299-303. PubMed ID: 12793336
[TBL] [Abstract][Full Text] [Related]
6. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
Hershman DL; Lacchetti C; Dworkin RH; Lavoie Smith EM; Bleeker J; Cavaletti G; Chauhan C; Gavin P; Lavino A; Lustberg MB; Paice J; Schneider B; Smith ML; Smith T; Terstriep S; Wagner-Johnston N; Bak K; Loprinzi CL;
J Clin Oncol; 2014 Jun; 32(18):1941-67. PubMed ID: 24733808
[TBL] [Abstract][Full Text] [Related]
7. Therapy of chemotherapy-induced peripheral neuropathy.
Kaley TJ; Deangelis LM
Br J Haematol; 2009 Apr; 145(1):3-14. PubMed ID: 19170681
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches.
Kachrani R; Santana A; Rogala B; Pawasauskas J
J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):141-152. PubMed ID: 32118502
[TBL] [Abstract][Full Text] [Related]
9. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
Amara S
Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives.
Ewertz M; Qvortrup C; Eckhoff L
Acta Oncol; 2015 May; 54(5):587-91. PubMed ID: 25751757
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy-induced peripheral neuropathy].
Noguchi E; Maeda Y
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1773-6. PubMed ID: 22083183
[TBL] [Abstract][Full Text] [Related]
12. Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis.
Kanbayashi Y; Hosokawa T; Okamoto K; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Taniwaki M
Anticancer Drugs; 2010 Oct; 21(9):877-81. PubMed ID: 20679888
[TBL] [Abstract][Full Text] [Related]
13. Acupuncture for chemotherapy-induced peripheral neuropathy (CIPN): a pilot study using neurography.
Schroeder S; Meyer-Hamme G; Epplée S
Acupunct Med; 2012 Mar; 30(1):4-7. PubMed ID: 22146780
[TBL] [Abstract][Full Text] [Related]
14. Effects of sweet bee venom pharmacopuncture treatment for chemotherapy-induced peripheral neuropathy: a case series.
Park JW; Jeon JH; Yoon J; Jung TY; Kwon KR; Cho CK; Lee YW; Sagar S; Wong R; Yoo HS
Integr Cancer Ther; 2012 Jun; 11(2):166-71. PubMed ID: 21715371
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic strategies for cancer treatment related peripheral neuropathies.
Pachman DR; Watson JC; Loprinzi CL
Curr Treat Options Oncol; 2014 Dec; 15(4):567-80. PubMed ID: 25119581
[TBL] [Abstract][Full Text] [Related]
16. Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms.
Hu LY; Mi WL; Wu GC; Wang YQ; Mao-Ying QL
Curr Neuropharmacol; 2019; 17(2):184-196. PubMed ID: 28925884
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy.
Hausheer FH; Schilsky RL; Bain S; Berghorn EJ; Lieberman F
Semin Oncol; 2006 Feb; 33(1):15-49. PubMed ID: 16473643
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy-induced peripheral neuropathy: an unresolved issue].
Velasco R; Bruna J
Neurologia; 2010 Mar; 25(2):116-31. PubMed ID: 20487712
[TBL] [Abstract][Full Text] [Related]
19. Sweet bee venom pharmacopuncture for chemotherapy-induced peripheral neuropathy.
Yoon J; Jeon JH; Lee YW; Cho CK; Kwon KR; Shin JE; Sagar S; Wong R; Yoo HS
J Acupunct Meridian Stud; 2012 Aug; 5(4):156-65. PubMed ID: 22898064
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
Staurengo-Ferrari L; Bonet IJM; Araldi D; Green PG; Levine JD
J Neurosci; 2022 Jan; 42(3):405-415. PubMed ID: 34880120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]